(Q35717674)

9 August 2017

1 reference

title

Biochemical and clinical evidence for uremic toxicity (English)

1 reference

9 August 2017

2

Raymond Vanholder

1 reference

9 August 2017

Tony Bouré

1

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

28

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

248-253

1 reference

Effect of dialysis dose and membrane flux in maintenance hemodialysis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Dissociation between dialysis adequacy and Kt/V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

The middle molecule hypothesis in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Inflammatory and atherosclerotic interactions in the depleted uremic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Maintaining low concentrations of plasma beta 2-microglobulin through continuous slow haemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Toxicity of free p-cresol: a prospective and cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

In vitro effect of advanced glycation end-products on human polymorphonuclear superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Advanced glycation and the immune system: stimulation, inhibition or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

Uremic Ultrafiltrate Inhibits Platelet-Activating Factor Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1594.2004.47315.X

10.1111/J.1525-1594.2004.47315.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference